Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin

Inflammation Research

Volumn 61, Issue 7, 2012, Pages 735-742

  Yehuda, Hila ^a   Soroka, Yoram ^b   Zlotkin Frušić, Marina ^b   Gilhar, Amos ^c   Milner, Yoram ^b   Tamir, Snait ^a,d  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d TEL HAI COLLEGE   (Israel)

Author keywords

4 Methylthiobutylisothiocyanate; Isothiocyanates; Psoriasis; Skin inflammation; Sulforaphane

Indexed keywords

DEXAMETHASONE; ERUCIN; INTERLEUKIN 1; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; SULFORAPHANE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; EX VIVO STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PSORIASIS;

ADOLESCENT; ADULT; ANIMALS; CELL LINE; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; ISOTHIOCYANATES; MICE; MICE, SCID; MIDDLE AGED; MONOCYTES; PSORIASIS; RNA, MESSENGER; SKIN; THIOCYANATES; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84865146604     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0465-3     Document Type: Article

References (36)

1. Zhang Y, Yao S, Li J. Vegetable-derived isothiocyanates: antiproliferative activity and mechanism of action. Proc Nutr Soc. 2006;65:68-75. (Pubitemid 43259986)
2. Halkier BA, Gershenzon J. Biology and biochemistry of glucosinolates. Annu Rev Plant Biol. 2006;57:303-33. (Pubitemid 44061027)
3. Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci. 2007;64:1105-27. (Pubitemid 46684547)
4. Jakubikova J, Bao Y, Sedlak J. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res. 2005;25:3375-86. (Pubitemid 41105214)
5. Thejass P, Kuttan G. Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factoralpha (TNF-alpha) production. Nitric Oxide. 2007;16:247-57. (Pubitemid 46149387)
6. Xiao D, Singh SV. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res. 2007;67:2239-46. (Pubitemid 46424243)
7. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J Biol Chem. 2001;276:32008-15.
8. Dey M, Ribnicky D, Kurmukov AG, Raskin I. In vitro and in vivo anti-inflammatory activity of a seed preparation containing phenethylisothiocyanate. J Pharmacol Exp Ther. 2006;317:326-33.
9. Rose P, Won YK, Ong CN, Whiteman M. Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide. 2005;12:237-43. (Pubitemid 40732393)
10. LeeYM,SeonMR,ChoHJ,KimJS, Park JH. Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin. J Mol Med. 2009;87:1251-61.
11. Nakamura Y, Miyoshi N, Takabayashi S, Osawa T. Benzyl isothiocyanate inhibits oxidative stress in mouse skin: involvement of attenuation of leukocyte infiltration. BioFactors. 2004;21:255-7. (Pubitemid 40921863)
12. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK, Yu R. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 2007;80:926-31. (Pubitemid 46186427)
13. Kerns ML, DePianto D, Dinkova-Kostova AT, Talalay P, Coulombe PA. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc Natl Acad Sci USA. 2007;104:14460-5. (Pubitemid 350003283)
14. Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, et al. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci USA. 2007;104:17500-5. (Pubitemid 350219867)
15. Prawan A, Saw CL, Khor TO, Keum YS, Yu S, Hu L, et al. Anti- NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem Biol Interact. 2009;179:202-11.
16. Nickoloff BJ, Xin H, Nestle FO, Qin JZ. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007;25:568-73. (Pubitemid 350103656)
17. Sabat R, Sterry W, Philipp S, Wolk K. Three decades of psoriasis research: where has it led us? Clin Dermatol. 2007;25:504-9. (Pubitemid 350087595)
18. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866-73.
19. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol. 2000;114:602-8. (Pubitemid 30415356)
20. Hakala JK, Lindstedt KA, Kovanen PT, Pentikainen MO. Lowdensity lipoprotein modified by macrophage-derived lysosomal hydrolases induces expression and secretion of IL-8 via p38 MAPK and NF-kappaB by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 2006;26:2504-9. (Pubitemid 44607472)
21. Yano S, Banno T, Walsh R, Blumenberg M. Transcriptional responses of human epidermal keratinocytes to cytokine interleukin- 1. J Cell Physiol. 2008;214:1-13. (Pubitemid 350220053)
22. Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK 3rd. Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol. 2004;13:193-222. (Pubitemid 38618076)
23. Takatori H, Kanno Y, Chen Z, O'Shea JJ. New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol. 2008;18:533-41.
24. Yehuda H, Khatib S, Sussan I, Musa R, Vaya J, Tamir S. Potential skin antiinflammatory effects of 4-methylthiobutylisothiocyanate (MTBI) isolated from rocket (Eruca sativa) seeds. Biofactors. 2009;35:295-305.
25. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45-50. (Pubitemid 46356230)
26. Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, et al. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol. 2010;159:842-55.
27. Gilhar A, Ullmann Y, Kerner H, Assy B, Shalaginov R, Serafimovich S, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol. 2002; 119:384-91. (Pubitemid 35001948)
28. Gilhar A, Bergman R, Assay B, Ullmann Y, Etzioni A. The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. J Invest Dermatol. 2010;131:118-24.
29. Gilhar A, Yaniv R, Assy B, Serafimovich S, Ullmann Y, Kalish RS. Fas pulls the trigger on psoriasis. Am J Pathol. 2006;168:170-5. (Pubitemid 43062570)
30. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol. 2008;76:967-73.
31. Melchini A, Traka MH. Biological profile of erucin: a new promising anticancer agent from cruciferous vegetables. Toxins. 2010;2:593-612.
32. Portugal-Cohen M, Soroka Y, Ma'or Z, Oron M, Zioni T, Bregegere FM, et al. Protective effects of a cream containing Dead Sea minerals against UVB-induced stress in human skin. Exp Dermatol. 2009;18:781-8.
33. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis. J Immunol. 2010; 184:5263-70.
34. O'Neill JL, Kalb RE. Ustekinumab in the therapy of chronic plaque psoriasis. Biologics. 2009;3:159-68.
35. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273-90. (Pubitemid 46175676)
36. Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol. 2007;57:1059-68.